Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Fusion Pharmaceuticals

09/05/2024 14:52

* Fusion Pharmaceuticals Inc  FUSN.OQ  reported a quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
March, higher than the same quarter last year, when the company
reported EPS of -45 cents.  The mean expectation of
eight analysts for the quarter was for a loss of 37 cents per
share. Wall Street expected results to range from -39 cents
to -34 cents per share.
    * Reported revenue was zero​; analysts expected $151.83
thousand. 
    * Fusion Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 40 cents​.
    * The company reported a quarterly loss of $33.67 million.
    * Fusion Pharmaceuticals Inc shares had risen by 0.4% this
quarter and gained 122.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 9.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 10
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Fusion
Pharmaceuticals Inc is $21.00 
This summary was machine generated from LSEG data May 9 at 01:52
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.37          -0.40          Missed
 Dec. 31 2023      -0.34          -0.39          Missed
 Sep. 30 2023      -0.40          -0.25          Beat
 Jun. 30 2023      -0.39          -0.38          Beat